Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice

Experimental Hematology

Volumn 43, Issue 2, 2015, Pages 110-114.e2

  Rao, Mahil ^a   Supakorndej, Teerawit ^a   Schmidt, Amy P ^a   Link, Daniel C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; OSTEOPROTEGERIN; COLONY STIMULATING FACTOR RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DONOR SELECTION; FETUS; FETUS LIVER; HEMATOPOIETIC STEM CELL; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM;

MUS;

ANIMALS; BONE MARROW CELLS; CHIMERA; FETUS; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; IMMUNOGLOBULIN FC FRAGMENTS; LIVER; MALE; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, COLONY-STIMULATING FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 84925019810     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.10.012     Document Type: Article

References (16)

1. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687-694. [erratum appears in Nat Immunol. 2002;3:787].
2. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
3. Semerad C.L., Christopher M.J., Liu F., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005, 106:3020-3027.
4. Christopher M.J., Liu F., Hilton M.J., Long F., Link D.C. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 2009, 114:1331-1339.
5. Christopher M.J., Rao M., Liu F., Woloszynek J.R., Link D.C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011, 208:251-260.
6. Chow A., Lucas D., Hidalgo A., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011, 208:261-271.
7. Winkler I.G., Sims N.A., Pettit A.R., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
8. Kollet O., Dar A., Shivtiel S., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006, 12:657-664.
9. Cho K.A., Joo S.Y., Han H.S., Ryu K.H., Woo S.Y. Osteoclast activation by receptor activator of NF-kappaB ligand enhances the mobilization of hematopoietic progenitor cells from the bone marrow in acute injury. Int J Mol Med 2010, 26:557-563.
10. Miyamoto K., Yoshida S., Kawasumi M., et al. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 2011, 208:2175-2181.
11. Liu F., Wu H.Y., Wesselschmidt R., Komaga T., Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1996, 5:491-501.
12. Dougall W.C., Glaccum M., Charrier K., et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999, 13:2412-2424.
13. Wu C.A., Pettit A.R., Toulson S., Grøndahl L., Mackie E.J., Cassady A.I. Responses invivo to purified poly(3-hydroxybutyrate-co-3-hydroxyvalerate) implanted in a murine tibial defect model. J Biomed Mater Res A 2009, 91:845-854.
14. Hashimoto D., Chow A., Noizat C., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
15. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
16. Ominsky M.S., Li X., Asuncion F.J., et al. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 2008, 23:672-682.